Efficacy, safety, pharmacokinetics, and pharmacodynamics of...

  • Main
  • 2017 / 06
  • Efficacy, safety, pharmacokinetics, and pharmacodynamics of...

Efficacy, safety, pharmacokinetics, and pharmacodynamics of filgotinib, a selective Janus kinase 1 inhibitor, after short-term treatment of rheumatoid arthritis: Results of two randomized Phase IIA trials

Vanhoutte, Frédéric, Mazur, Minodora, Voloshyn, Oleksandr, Stanislavchuk, Mykola, Van der Aa, Annegret, Namour, Florence, Galien, René, Meuleners, Luc, van ‘t Klooster, Gerben
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Arthritis & Rheumatology
DOI:
10.1002/art.40186
Date:
June, 2017
File:
PDF, 1014 KB
english, 2017
Conversion to is in progress
Conversion to is failed